Enavate Sciences (Patient Square Capital) — VC Intelligence

Recent changes

Nov 5, 2025Nov 5, 2025Invested in Braveheart Bio (Series A, $185M) PR Newswire

Portfolio

1 total

Recent Investment Activity

Date	Company	Event	Amount	Valuation	Investors	Source
Nov 5, 2025	Braveheart Bio	Series A	$185M	—	Andreessen Horowitz Forbion Capital Partners OrbiMed Advisors Enavate Sciences (Patient Square Capital)Frazier Life Sciences	PR Newswire

Co-Investors

Andreessen Horowitz · 1 shared Forbion Capital Partners · 1 shared Frazier Life Sciences · 1 shared OrbiMed Advisors · 1 shared

Sources & methodologyshow

Where these figures come from

PR Newswireprimary source1 fact

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction